Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 235

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 235
---
 an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.

Securities legislation in
certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including
any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser
within the time limit prescribed by the securities legislation of the purchaser’s province or territory. The purchaser should refer
to any applicable provisions of the securities legislation of the purchaser’s province or territory for particulars of these rights
or consult with a legal advisor.

China

The information in this document
does not constitute a public offer of the securities, whether by way of sale or subscription, in the People’s Republic of China
(excluding, for purposes of this paragraph, Hong Kong Special Administrative Region, Macau Special Administrative Region and Taiwan).
The securities may not be offered or sold directly or indirectly in the PRC to legal or natural persons other than directly to “qualified
domestic institutional investors.”

European Economic Area—Belgium, Germany, Luxembourg and Netherlands

The information in this document
has been prepared on the basis that all offers of securities will be made pursuant to an exemption under the Directive 2003/71/EC, or
the Prospectus Directive, as implemented in Member States of the European Economic Area, each, a Relevant Member State, from the requirement
to produce a prospectus for offers of securities. An offer to the public of securities has not been made, and may not be made, in a Relevant
Member State except pursuant to one of the following exemptions under the Prospectus Directive as implemented in that Relevant Member
State:

| ● | to legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities;                                                                                                                                                                                                             |
| ● | to any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance sheet of more than €43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an annual net turnover of more than €50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements); |
| ● | to fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e)